Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
3D models of human ERα and ERβ complexed with coumestrol.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.
lipid-specific IgM bands in csf associated with a reduced risk of developing pml during treatment with natalizumab.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
Anejaculatory infertility due to multiple sclerosis.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
Development of the Brief Inventory of Perceived Stress.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.

Pages